SCHEMBL3261669

SCHEMBL3261669

Cc1[nH]c2c(F)c(F)ccc2c1CC(N)=O

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.44
GAA P10253 3/20 0.44
MAPT P10636 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ANO1 Q5XXA6 1/20 0.37
ALDH1A1 P00352 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
GPR17 Q13304 3/20 0.36
SIRT1 Q96EB6 5/20 0.36
APOL1 O14791 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
P2RX7 Q99572 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3636076 0.82 KDM4E (0.55) KDM4EGAAMAPTMEN1KMT2A
SCHEMBL3638375 0.79 CYP1A2 (0.45) KDM4EGAAMAPTMEN1KMT2A
SCHEMBL3232286 0.78 SMN1; SMN2 (0.55) KDM4EGAAMAPTMEN1KMT2A
SCHEMBL3379855 0.78 MAP2 (0.47) KDM4EGAAMAPTMEN1KMT2A
SCHEMBL3263047 0.78 MAPT (0.39) KDM4EGAAMAPTMEN1KMT2A
SCHEMBL3639386 0.77 CYP1A2 (0.57) KDM4EGAAMAPTMEN1KMT2A
SCHEMBL3264986 0.76 MAPT (0.75) KDM4EGAAMAPTMEN1KMT2A
SCHEMBL3261013 0.75 SIRT1 (0.39) KDM4EGAAMAPTMEN1KMT2A
SCHEMBL3639755 0.74 CYP1A2 (0.41) KDM4EGAAMAPTMEN1KMT2A
SCHEMBL3382868 0.73 KDM4E (0.55) KDM4EGAAMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010012396-A1 5,6 SUBSTITUTED BENZAMIDE DERIVATIVES AS MODULATORS OF THE EP<SB>2 </SB>RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 WO claimed
EP-2149552-A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors Bayer Schering Pharma AG (DE) 2010-02-03 EP claimed
EP-2149552-A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors Bayer Schering Pharma AG (DE) 2010-02-03 EP disclosed